Stem cell tourism: The new "snake oil" of the 21st century

Asian Biomedicine

Volumn 3, Issue 3, 2009, Pages 339-342

  Dedmon, Robert E ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE   (United States)

Author keywords

Medical tourism; Stem cell guidelines; Stem cell tourism

Indexed keywords

ATAXIA TELANGIECTASIA; BRAIN TUMOR; DIABETES MELLITUS; HEALTH CARE COST; HEART DISEASE; HUMAN; MEDICAL TOURISM; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NONHUMAN; NOTE; PARKINSON DISEASE; PRACTICE GUIDELINE; SPINAL CORD TUMOR; STEM CELL TRANSPLANTATION; TOURISM;

EID: 70349316863     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (22)

1. Nelson B. Stem cell researchers face down stem cell tourism. Nature Reports. Stem cells. 05 June 2008: doi:10.1038/stemcells.2008.89.
2. Sheldon T. Holland bans private stem cell therapy. BMJ. 2007; 334:12.
3. Sheldon T. Dutch clinic is ordered to stop giving stem cell therapy. BMJ. 2006; 333:770.
4. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Lowenthal R, Trakhtenbrot L, et al. Donorderived brain tumor following neural stem cell transplantation in an Ataxia Telangiectasia patient. www.plosmedicine.org. Feb 2009; 6:e1000029.
5. Moore T. Bone marrow transplantation. http://emedicine.medscape.com/ article/1014514-overview. Accessed 24 FEB 2009.
6. Thomson JA, Kalishman J, Golos TG, Durning CP, Harris CP, Becker RA, Hearn JP. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA. 1995; 92:7844-7848
7. Junying Y, Vodyanik MA, Smuga-Otto K, Antosiewicz- Bourget J, Franc JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318:1917-1920
8. Wikipedia. Stem cell controversy. http://en.wikipedia.org/wiki/Stem-cell- controversy. Accessed 26 FEB 2009. This page last modified on 26FEB2009.
9. Nature. www.nature.com/nrd/journal/v8/n3/full/nrd 2848.html. Accessed 27 FEB 2009.
10. Kierstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, et al. Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neuroscience. 2005; 25:4694-4705
11. Vots AC, Bielby RC, Tolley NS, Nerem R, Polak JM. Stem cells. Review. 2005; 366:592-602.
12. Burt RK, Loh Y, Cohen B, Steforky D, Balabano R, Katsamakis G, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsingremitting multiple sclerosis: a phase l/ll study. The Lancet Neurology. 2009, 244-253 doi: 10.1016/S1474-4422(09)70017-1. Accessed 22 FEB 2009.
13. Clinical Trials. www.clinicaltrials.gov. Accessed 22 FEB 2009.
14. Texas Heart Institute. www.texasheartinstitute.org/Research/ StemCellCenter/index.cfm.
15. International Society for Stem Cell Research. www. isscr.org. Accessed 26 FEB 2009.
16. Hyun I, Lindvail O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, et al. New ISSCR guidelines. Cell Stem Cell. 2008; 3:607-609
17. Lau D, Ogbogu L, Taylor B, Stafinski T, Menon D, Caulfield T. Stem cell clinics online: the direct-toconsumer portrayal of stem cell medicine. Cell Stem Cell. 2008; 3:591-594 doi:10.1016/j.stem.2008. 11.001.
18. Lonneke MLdL, Breteler MB. Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5:525-535
19. Endocrine today. Fuller Albright: pioneer in the field of endocrinology. Posted. 25 Nov. 7 2008; www.endocrinetoday.com/view.aspx?rid=33062. Accessed 13 MAR 2009.
20. Schwartz TB. How to learn from patients: Fuller Albright's exploration of adrenal function. Ann Intern Med. 1995; 123:225-229
21. Sanberg PS. Neural stem cells for Parkinson's disease: To protect and repair. Proc Natl Acad Sci USA. 2007; 104:11869-11870
22. Redmond de, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA. 2007; 104: 12175-12180